Tata 1 mg

OVERVIEW - TATA 1MG HEALTHCARE SOLUTIONS PRIVATE LIMITED Tata 1Mg Healthcare Solutions Private Limited is an unlisted private company incorporated on 06 July, 2016. It is classified as a private limited company and is located in South Delhi, Delhi. It's authorized share capital is INR 538.76 cr and the total paid-up capital is INR 534.37 cr. Tata 1mg Healthcare Solutions's operating revenues range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2022. It's EBITDA has decreased by -1,299.36 % over the previous year. At the same time, it's book networth has decreased by -52.46 %. Other performance and liquidity ratios are Description: The company trades and distributes generic drugs such as capsules, syrups and suspension, drops, and tablets. Products & Services: Tablets, Capsules, Syrup & Suspension, Dry Syrup, Drops, Injections, Ointments, Protein Powders, Others etc Category: Distributor The current status of Tata 1Mg Healthcare Solutions Private Limited is - Active. The last reported AGM (Annual General Meeting) of Tata 1Mg Healthcare Solutions Private Limited, per our records, was held on 20 July, 2022. Tata 1Mg Healthcare Solutions Private Limited has three directors - The Corporate Identification Number (CIN) of Tata 1Mg Healthcare Solutions Private Limited is U24290DL2016PTC302634. The registered office of Tata 1Mg Healthcare Solutions Private Limited is at Level 3, Vasant Square Mall, Pocket V, Sector B, Vasant Kunj, New Delhi, South Delhi, Delhi. T...

“They (1mg) are keen to bring the one-hour delivery to consumers. There is a lot of demand for it, which has only increased after the pandemic as people need various medicines and healthcare-related products in quick time. They are working on expediting the launch,” a person aware of the matter said. When contacted, 1mg cofounder and CEO Prashant Tandon did not comment on the matter. It is tough to manage in the express delivery space, but it has its advantages and disadvantages, an entrepreneur who ran a firm in the space said. “Express delivery can bring volumes over a period of time but its biggest challenge is lower average selling price. Delivery costs are roughly around the same for an order but while factoring in returns or exchanges, the smaller order value hits your margins.” According to him, express delivery is a long-term play where one has to give it four-five years to be able to see desired results at scale. “You have to fight for it for three-five years with adequate capital for the vertical. For example, in a city like Bengaluru, you would need four warehouses to service express delivery compared to one or two for 24-48-hour deliveries. In Mumbai—strictly within city limits — this number would be seven-eight, while the Delhi-NCR region would need close to a dozen,” this startup founder added. Capital is Crucial The recent capital infusion of over $100 million from the Tatas and other investors would help 1mg in building out this vertical. Most e-pharmacies ...